Dr. Isabel Sharkar, NMD, is co-founder of Indigo Integrative Health Clinic in Washington, D.C., a thriving clinic that has been serving the local community in health restoration and body optimization for over a decade. Being in constant pursuit for truth and healing Dr. Isabel graduated in 2011 from Southwest College of Naturopathic Medicine as a Doctor of Naturopathic Medicine.
Caroline serves as Chief Operating Officer of Indigo Integrative Health Clinic, where she drives the expansion of Indigo’s pioneering root-cause approach to medical care.
Drawing on her extensive experience as a Parsley Health provider, educator and board-certified Health Coach, Caroline combines operational leadership with clinical insight to advance Indigo’s mission of delivering transformative, personalized care.
GLP-1 receptor agonists — drugs like Ozempic, Wegovy, and Mounjaro — have transformed how we treat obesity and metabolic disease. But are they right for you? Here's what the science actually says.
Key Takeaways
GLP-1 agonists mimic a natural hormone that regulates blood sugar and appetite.
Originally developed for type 2 diabetes, drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)were later found to produce significant weight loss — even in patients without diabetes.
That discovery led to FDA approval for obesity treatment and a cultural moment that has made these medications impossible to ignore.
These drugs act on multiple systems in the body simultaneously:
The result is a coordinated reduction in hunger and blood sugar — which is why the weight loss results have been so striking.
Both are effective. But they work differently.
Semaglutide targets the GLP-1 receptor only. It produces meaningful weight loss and improved blood sugar control, and it has the most long-term safety data.
Tirzepatide targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)receptors. Clinical trials show greater average weight loss compared tosemaglutide. Patients who plateau on semaglutide sometimes switch totirzepatide for additional benefit.
Retatrutide — the next generation — targets three receptors (GLP-1, GIP, and glucagon) and has shown up to 25% weight loss in early studies.
Oral forms are now available, with more in the pipeline.
Real-world head-to-head trials betweensemaglutide and tirzepatide are still limited. The best choice depends on your health history, goals, and how your body responds — something your Indigo Health Clinic provider can help you determine.
No medication is without risk. The most common side effects are gastrointestinal and typically improve with time.
Common:
Serious but rare:
Less discussed but important:
At Indigo Health Clinic, we require thyroid and gallbladder ultrasounds before starting any GLP-1 therapy. Annual ultrasounds are part of our ongoing monitoring protocol.
Most side effects are manageable with the right approach:
For most people, yes — at least partially.
GLP-1 medications regulate hunger signals. They don't permanently reset your metabolism. When the medication stops, hunger cues often return.
This mirrors outcomes seen with both dietary interventions and bariatric surgery.
Sustainable results require sustainable habits: quality nutrition, adequate protein, strength training, hormonal balance, and gut health monitoring. The medication creates the conditions for change — lifestyle is what makes it last.
Emerging research points to a range of potential benefits, though it's not always clear whether these stem from weight loss itself or the medication's direct effects:
Before starting, ask yourself:
These aren't reasons to avoid treatment. They're the right questions to ask so you start with realistic expectations and a solid plan.
GLP-1 receptor agonists are among the most significant advances in metabolic medicine in decades. But they aren't a standalone solution.
Used with the right clinical oversight, nutrition strategy, and movement practices, they can be a powerful tool for reclaiming your health — not just losing weight.
If you're considering GLP-1 therapy, the best next step is a conversation with an experienced provider who understands the full picture.
Questions? Reach us atdiscovery@indigohealthclinic.com or (202) 840-6622, Monday–Friday, 9AM–5PM EST.
This content is provided by Indigo Integrative Health Clinic for educational purposes only. It does not constitute medical advice, a diagnosis, or a treatment recommendation, and does not establish a provider-patient relationship. Individual health conditions vary — information presented here may not apply to your specific situation. Always consult a qualified, licensed healthcare provider before making decisions about your health, medications, supplements, or treatment plan.
March is here, and for most people, the momentum of January has already faded. If your health goals have quietly slipped away, you're not alone — and it's not about willpower. It's about strategy.
Still experiencing fatigue, brain fog, or inflammation after Lyme treatment? Discover why persistent Lyme symptoms often continue beyond infection, and how immune balance, nervous system regulation, and a systems-based approach can support long-term recovery.
Learn when IV therapy becomes the next step after supplements. Discover how IV nutrient infusions support absorption, fatigue, inflammation, and recovery through precision integrative care.
Hours of Operation
Monday - Friday
9am - 5pm
